Richard MD - InVivo Therapeutics CEO and Presidentident
CEO
Richard MD is CEO and Presidentident of InVivo Therapeutics Holdings
Age | 66 |
Phone | 617 863 5500 |
Web | https://www.invivotherapeutics.com |
InVivo Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.5371) % which means that it has lost $0.5371 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9811) %, meaning that it created substantial loss on money invested by shareholders. InVivo Therapeutics' management efficiency ratios could be used to measure how well InVivo Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.InVivo Therapeutics Holdings currently holds 949 K in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. InVivo Therapeutics has a current ratio of 5.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about InVivo Therapeutics' use of debt, we should always consider it together with its cash and equity.
Similar Executives
Found 8 records | CEO Age | ||
Gareth Sheridan | Nutriband | 35 | |
Jason Okazaki | Assembly Biosciences | 49 | |
Mohamed MBA | Longeveron LLC | 63 | |
Nevan JD | Rezolute | 58 | |
Shaun Bagai | RenovoRx | 48 | |
Richard Cunningham | Anebulo Pharmaceuticals | 54 | |
Mohamed Hashad | Longeveron LLC | 62 | |
Jason JD | Assembly Biosciences | 49 |
Management Performance
Return On Equity | -0.98 | |||
Return On Asset | -0.54 |
InVivo Therapeutics Leadership Team
Elected by the shareholders, the InVivo Therapeutics' board of directors comprises two types of representatives: InVivo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InVivo. The board's role is to monitor InVivo Therapeutics' management team and ensure that shareholders' interests are well served. InVivo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InVivo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jerome Gangitano, VP Operations | ||
Joseph MD, CoFounder | ||
Richard Christopher, CFO, Treasurer | ||
Dr Langer, CoFounder Board | ||
MD FACP, Consultant | ||
Heather JD, Chief Counsel | ||
Richard MD, CEO and Presidentident | ||
Richard Toselli, Chief Medical Officer | ||
Joseph Vacanti, CoFounder |
InVivo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InVivo Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.98 | |||
Return On Asset | -0.54 | |||
Current Valuation | (7.59 M) | |||
Shares Outstanding | 3.11 M | |||
Shares Owned By Insiders | 0.02 % | |||
Shares Owned By Institutions | 3.44 % | |||
Number Of Shares Shorted | 17.63 K | |||
Price To Earning | (1.90) X | |||
Price To Book | 0.1 X | |||
EBITDA | (9.8 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |